Catalogo dei prodotti della ricerca

DEL MANSO, MARTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 226
NA - Nord America 148
AS - Asia 45
AF - Africa 4
SA - Sud America 1
Totale 424
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 149
US - Stati Uniti d'America 146
RO - Romania 38
SG - Singapore 33
BG - Bulgaria 14
IN - India 9
FI - Finlandia 6
SE - Svezia 5
DE - Germania 4
FR - Francia 4
CN - Cina 2
GB - Regno Unito 2
MA - Marocco 2
TG - Togo 2
BR - Brasile 1
CA - Canada 1
ES - Italia 1
MK - Macedonia 1
MX - Messico 1
RU - Federazione Russa 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 424
Salva come PNG Salva come JPEG
Città #
Rome 59
Horia 35
Fairfield 24
Milan 24
Ashburn 16
Singapore 15
Sofia 14
Chandler 13
New York 10
Wilmington 9
Seattle 8
Cambridge 7
San Paolo di Civitate 6
Woodbridge 6
Helsinki 5
Houston 5
Marseille 4
Bologna 3
Cesena 3
Lawrence 3
Lodi 3
Princeton 3
San Diego 3
Ann Arbor 2
Boston 2
Cagliari 2
Campobasso 2
Casablanca 2
Castelvetro Piacentino 2
Colorno 2
Faridabad 2
Florence 2
Frankfurt am Main 2
Genoa 2
Isorella 2
Lomé 2
Millbury 2
Pocasset 2
Reggio Emilia 2
Villaurbana 2
Armunia 1
Bitola 1
Bühl 1
Council Bluffs 1
Dallas 1
Fremont 1
Hebei 1
Kumar 1
Labico 1
Lappeenranta 1
London 1
Mexico City 1
Nanjing 1
Oxford 1
Pontenure 1
Pune 1
Redmond 1
Sacramento 1
St Petersburg 1
Strevi 1
São Paulo 1
Tashkent 1
Toronto 1
Turin 1
Urbino 1
Totale 337
Salva come PNG Salva come JPEG
Nome #
Towards elimination of measles and rubella in Italy. Progress and challenges 109
Differences in the clinical characteristics of COVID-19 patients who died in hospital during different phases of the pandemic: national data from Italy 90
Meningiti, meningo-encefaliti ed encefaliti da virus Toscana in Italia, 2016-2021. Punta dell’iceberg di una arbovirosi endemica poco conosciuta 44
National immunization policies and practices for migrants in EU/EEA countries 30
Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy. A retrospective matched cohort study 24
The impact of rotavirus vaccination on discharges for pediatric gastroenteritis in Italy. An eleven year (2009–2019) nationwide analysis 24
Il sistema di sorveglianza basato su eventi in Italia dal 2009 al 2021. Verso una intelligence di sanità pubblica 23
Rapid increase in neuroinvasive west Nile virus infections in humans, Italy, July 2022 16
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy. A retrospective analysis of January-April, 2022 15
Relative effectiveness of monovalent and bivalent mrna boosters in preventing severe covid-19 due to omicron ba.5 infection up to 4 months post-administration in people aged 60 years or older in Italy. A retrospective matched cohort study 14
Estimated effectiveness of a primary cycle of protein recombinant vaccine nvx-cov2373 against COVID-19 12
Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy. Update on the 28th of march 2021 12
Impatto del COVID-19 dopo l’inizio della vaccinazione in gruppi di popolazione a rischio, tra cui gli immunocompromessi. Italia 2021-2023 10
Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023 10
Impatto della vaccinazione e della pregressa diagnosi sul rischio di infezione e di malattia severa associata a SARS-CoV-2. Un’analisi dei casi diagnosticati nel mese di ottobre 2022 10
Microbiologically confirmed infections and antibiotic-resistance in a national surveillance study of hospitalised patients who died with COVID-19, Italy 2020–2021 9
Valutazione della qualità delle notifiche di decesso associate a COVID-19 riportate al sistema di sorveglianza integrata COVID-19 ISS: confronto con la rilevazione sulle cause di morte dell’Istat - Italia, 2020 8
Risk and protective factors for {sars}-{cov}-2 reinfections, surveillance data, Italy, August 2021 to March 2022 6
null 6
Effectiveness against severe COVID-19 of a seasonal booster dose of bivalent (original/Omicron BA.4-5) mRNA vaccines in persons aged ≥60 years. Estimates over calendar time and by time since administration during prevalent circulation of different Omicron subvariants, Italy, 2022–2023 6
Infezione da SARS-CoV-2: minore gravità clinica della variante Omicron rispetto alla variante Delta 5
Comorbidity status of deceased COVID-19 in-patients in Italy 4
Intelligent Natural Language Processing for Epidemic Intelligence 4
COVID-19 integrated surveillance in Italy: Outputs and related activities 4
Risk of breakthrough infection and hospitalisation after COVID-19 primary vaccination by HIV status in four Italian regions during 2021 4
Spatial spread of COVID-19 during the early pandemic phase in Italy 3
null 3
Valutazione di modelli basati sul Propensity Score per la stima dell’efficacia vaccinale contro forme gravi di COVID-19 in studi di coorte retrospettivi 2
Totale 507
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.785
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.785
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 0 0 0 0 0 10 0
2020/2021108 2 0 1 54 0 4 19 4 5 12 3 4
2021/202248 3 1 3 3 4 14 0 1 3 2 7 7
2022/202360 7 14 5 3 2 4 1 10 3 2 3 6
2023/2024267 1 11 17 46 18 38 4 32 13 12 29 46
2024/202514 14 0 0 0 0 0 0 0 0 0 0 0
Totale 507